165 related articles for article (PubMed ID: 26757339)
1. Cystatin C as a p53-inducible apoptotic mediator that regulates cathepsin L activity.
Mori J; Tanikawa C; Funauchi Y; Lo PH; Nakamura Y; Matsuda K
Cancer Sci; 2016 Mar; 107(3):298-306. PubMed ID: 26757339
[TBL] [Abstract][Full Text] [Related]
2. Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells.
Wilder CL; Walton C; Watson V; Stewart FAA; Johnson J; Peyton SR; Payne CK; Odero-Marah V; Platt MO
Int J Biochem Cell Biol; 2016 Oct; 79():199-208. PubMed ID: 27592448
[TBL] [Abstract][Full Text] [Related]
3. EPSIN 3, A Novel p53 Target, Regulates the Apoptotic Pathway and Gastric Carcinogenesis.
Mori J; Tanikawa C; Ohnishi N; Funauchi Y; Toyoshima O; Ueda K; Matsuda K
Neoplasia; 2017 Mar; 19(3):185-195. PubMed ID: 28152424
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional induction of protein kinase C delta by p53 tumor suppressor in the apoptotic response to DNA damage.
Dashzeveg N; Yogosawa S; Yoshida K
Cancer Lett; 2016 Apr; 374(1):167-174. PubMed ID: 26884258
[TBL] [Abstract][Full Text] [Related]
5. hCLCA2 Is a p53-Inducible Inhibitor of Breast Cancer Cell Proliferation.
Walia V; Ding M; Kumar S; Nie D; Premkumar LS; Elble RC
Cancer Res; 2009 Aug; 69(16):6624-32. PubMed ID: 19654313
[TBL] [Abstract][Full Text] [Related]
6. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
Lin J; Tang H; Jin X; Jia G; Hsieh JT
Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tubular recycling endosome biogenesis by the p53-MICALL1 pathway.
Takahashi Y; Tanikawa C; Miyamoto T; Hirata M; Wang G; Ueda K; Komatsu T; Matsuda K
Int J Oncol; 2017 Aug; 51(2):724-736. PubMed ID: 28714518
[TBL] [Abstract][Full Text] [Related]
8. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T
Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838
[TBL] [Abstract][Full Text] [Related]
9. TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death.
Kuribayashi K; Krigsfeld G; Wang W; Xu J; Mayes PA; Dicker DT; Wu GS; El-Deiry WS
Cancer Biol Ther; 2008 Dec; 7(12):2034-8. PubMed ID: 19106633
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.
Yoon H; Liyanarachchi S; Wright FA; Davuluri R; Lockman JC; de la Chapelle A; Pellegata NS
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15632-7. PubMed ID: 12438652
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cathepsin L lowers the apoptotic threshold of glioblastoma cells by up-regulating p53 and transcription of caspases 3 and 7.
Kenig S; Frangež R; Pucer A; Lah T
Apoptosis; 2011 Jul; 16(7):671-82. PubMed ID: 21484410
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
Huang Y; Tan M; Gosink M; Wang KK; Sun Y
Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
[TBL] [Abstract][Full Text] [Related]
13. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of the carboxylesterase 2 gene by the p53 pathway.
Choi W; Cogdell D; Feng Y; Hamilton SR; Zhang W
Cancer Biol Ther; 2006 Nov; 5(11):1450-6. PubMed ID: 16963839
[TBL] [Abstract][Full Text] [Related]
15. 5-Lipoxygenase is a direct p53 target gene in humans.
Gilbert B; Ahmad K; Roos J; Lehmann C; Chiba T; Ulrich-Rückert S; Smeenk L; van Heeringen S; Maier TJ; Groner B; Steinhilber D
Biochim Biophys Acta; 2015 Aug; 1849(8):1003-16. PubMed ID: 26070487
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Cathepsin S Induces Mitochondrial ROS That Sensitizes TRAIL-Mediated Apoptosis Through p53-Mediated Downregulation of Bcl-2 and c-FLIP.
Seo BR; Min KJ; Woo SM; Choe M; Choi KS; Lee YK; Yoon G; Kwon TK
Antioxid Redox Signal; 2017 Aug; 27(4):215-233. PubMed ID: 27927016
[TBL] [Abstract][Full Text] [Related]
17. p53CSV, a novel p53-inducible gene involved in the p53-dependent cell-survival pathway.
Park WR; Nakamura Y
Cancer Res; 2005 Feb; 65(4):1197-206. PubMed ID: 15735003
[TBL] [Abstract][Full Text] [Related]
18. Expression of DNA damage checkpoint 53BP1 is correlated with prognosis, cell proliferation and apoptosis in colorectal cancer.
Bi J; Huang A; Liu T; Zhang T; Ma H
Int J Clin Exp Pathol; 2015; 8(6):6070-82. PubMed ID: 26261485
[TBL] [Abstract][Full Text] [Related]
19. Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment.
Laurent-Matha V; Huesgen PF; Masson O; Derocq D; Prébois C; Gary-Bobo M; Lecaille F; Rebière B; Meurice G; Oréar C; Hollingsworth RE; Abrahamson M; Lalmanach G; Overall CM; Liaudet-Coopman E
FASEB J; 2012 Dec; 26(12):5172-81. PubMed ID: 22898924
[TBL] [Abstract][Full Text] [Related]
20. p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3.
Hünten S; Hermeking H
Oncotarget; 2015 Jun; 6(18):15842-56. PubMed ID: 26158294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
